Oyama

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Multiple sclerosis

Closed trials

• Completed

  Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

  NCT04940065· Novartis Pharmaceuticals· Source